(NASDAQ: BEAT), a medical technology company focused on transforming cardiac care by providing powerful personalized insights ...
Heartbeam Inc.'s algorithms performed as well on a standard 12-lead electrocardiography (ECG) as on its 3D ECG system in the detection of atrial fibrillation, atrial flutter and sinus rhythm, based on ...
HeartBeam (NASDAQ: BEAT), a medical technology company focused on transforming cardiac care with personalized insights, ...
Please provide your email address to receive an email when new articles are posted on . The AMALFI trial evaluated a completely remote approach to atrial fibrillation screening. Remote screening with ...
The AMALFI trial investigated whether atrial fibrillation (AF) detection rates would be increased with a screening approach that involved older patients at moderate-to-high stroke risk wearing an ECG ...
Most heart palpitations are harmless. But some signal a serious risk. Here are the key red flags a top heart doctor says not to ignore.
(NASDAQ: BEAT), a medical technology company focused on transforming cardiac care by providing powerful personalized insights, today announced that CEO Robert Eno and CFO Timothy Cruickshank will ...
During a workout it is easy to mistake warning signs for harmless strain. A stitch, a pulled muscle, or reflux can mimic ...
Remote screening for asymptomatic atrial fibrillation through a patch-based continuous ambulatory ECG monitor could help increase atrial fibrillation diagnosis.
This case highlights the diagnostic value of Holter ECG monitoring in uncovering spontaneous arrhythmia mechanisms. Several ...